Travere Therapeutics (TVTX) Capital Expenditures (QoQ) (2014 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 150.00% |
| Sep 30, 2023 | 233.33% |
| Jun 30, 2023 | -99.52% |
| Mar 31, 2023 | 2,000.00% |
| Dec 31, 2022 | 130.77% |
| Sep 30, 2022 | -23.53% |
| Jun 30, 2022 | -87.02% |
| Mar 31, 2022 | -14.94% |
| Dec 31, 2021 | -55.87% |
| Sep 30, 2021 | 238.83% |
| Jun 30, 2021 | -97.71% |
| Mar 31, 2021 | 538.11% |
| Dec 31, 2020 | -142.61% |
| Sep 30, 2020 | 676.77% |
| Jun 30, 2020 | 49.04% |
| Mar 31, 2020 | 328.57% |
| Dec 31, 2019 | -134.34% |
| Sep 30, 2019 | 13,150.00% |
| Jun 30, 2019 | -89.47% |
| Mar 31, 2019 | 102.61% |
| Dec 31, 2018 | -676.98% |
| Sep 30, 2018 | -77.58% |
| Jun 30, 2018 | 1,341.03% |
| Mar 31, 2018 | 107.09% |
| Dec 31, 2017 | -244.36% |
| Sep 30, 2017 | 74.77% |
| Jun 30, 2017 | -73.99% |
| Mar 31, 2017 | -38.70% |
| Dec 31, 2016 | 3,594.59% |
| Mar 31, 2016 | 284.62% |
| Dec 31, 2015 | -316.67% |
| Sep 30, 2015 | 50.00% |
| Jun 30, 2015 | -84.00% |
| Mar 31, 2015 | -69.51% |
| Dec 31, 2014 | -47.77% |
| Sep 30, 2014 | -39.11% |
| Jun 30, 2014 | 55.20% |
| Mar 31, 2014 | 75.34% |